Drug discovery

Could there be a drug that can both treat and protect against COVID-19? The answer may be found in antibody drugs, a promising therapeutic modality against the coronavirus.

Uttam Surana shares how SiNOPSEE Therapeutics, the biopharmaceutical startup he co-founded, is developing drugs to block angiogenesis in cancer and degenerative eye conditions.

Tipped off by artificial intelligence, a research team is testing whether a rheumatoid arthritis drug could be repurposed as a COVID-19 treatment.

Scientists are one step closer to developing effective treatments against Plasmodium vivax parasites, thanks to the ability to culture one of its closest cousins.

A*STAR scientists have developed a method to measure crucial protein-protein interactions in cancer cells, with implications for drug design and discovery.

A three-dimensional liver organoid model for studying dormant malaria parasites may pave the way for better antimalarial drugs.

Injecting flies with snail venom could help us discover molecules for developing new drugs

Reverse-engineering
white blood cells into stem cells offers promise for a novel test that could help
in delivering less toxic treatment regimens

Fluorescent molecular rotors developed by the A*STAR Molecular Engineering Laboratory promise to revolutionize the search for new anticancer drugs

The newly established A*STAR D3 platform is driving forward drug discovery and development in Singapore

The A*STAR Experimental Therapeutic Centre strengthens its educational initiative through its popular Drug Discovery Course